Why it was recalled
Labeling: Label Mix-up
Product description
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Lot numbers, UPCs & expiration codes
Lot # 1030023, Exp Date: 06/30/2027.
Where it was sold
US Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0840-2026
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- Aug 19, 2026
- FDA report date
- Sep 9, 2026
- Quantity
- 10,953 cartons.
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- American Health Packaging
Original FDA data
Every field from FDA enforcement report D-0840-2026, exactly as published.
Show all FDA fields
- City
- Columbus
- State
- OH
- Status
- Ongoing
- Country
- United States
- Event ID
- 99674
- Address
- 2550 John Glenn Ave Ste A
- Code information
- Lot # 1030023, Exp Date: 06/30/2027.
- Postal code
- 43217-1188
- Report date
- Sep 9, 2026
- Product type
- Drugs
- Recall number
- D-0840-2026
- Classification
- Class III
- Recalling firm
- American Health Packaging
- Product quantity
- 10,953 cartons.
- Reason for recall
- Labeling: Label Mix-up
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
- Distribution pattern
- US Nationwide.
- Recall initiation date
- Aug 19, 2026
- Initial firm notification
- Letter
- Center classification date
- Sep 14, 2026